Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01059214 · ClinicalTrials.gov registry record
Cardiac MRI for Patients Enrolled in INFUSE-AMI
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 455
- Enrollment target
NCT01059214 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 455 participants.
The verdict
NCT01059214 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 455 participants
- Enrollment target
Study Summary
Background: * INFUSE AMI is an ongoing clinical trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with specific kinds of heart attacks caused by blood clots. * To evaluate the effect of the heart attack on the heart tissue and function, participants in the INFUSE-AMI study will have magnetic resonance imaging (MRI) scans of the heart at specific times after their heart attack. Objectives: \- To perform cardiac MRI scans on patients who are participating in the INFUSE-AMI study. Eligibility: \- Individuals at least 18 years of age who are enrolled in the INFUSE-AMI study. Design: * Participants will have an MRI scan of the heart about 5 days and between 23 and 44 days after their heart attack. The MRI scan at day 5 is optional. * Participants will provide a blood sample prior to the MRI scan. * During the scan, participants will be given a contrast drug to show the blood flow to and within the heart. An electrocardiogram will be used to monitor the heart during the procedure. * No other treatment will be provided in this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 455 participants |
| Start Date | 2009-12-10 |
| Est. Completion | 2012-10-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01059214
The ClinicalTrials.gov registry entry for NCT01059214 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 455 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01059214 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01059214 about?
NCT01059214 is a clinical study titled "Cardiac MRI for Patients Enrolled in INFUSE-AMI". Background: * INFUSE AMI is an ongoing clinical trial examining how patients with heart attacks are treated. The study's aim is to help determine the best way to treat patients with specific kinds of heart attacks caused by blood clots. * To evaluate the effect of the heart attack on the heart tiss...
What is the current status of trial NCT01059214?
This trial is currently completed. The enrollment target is 455 participants. The study started on 2009-12-10. Estimated completion is 2012-10-11.
Who is sponsoring clinical trial NCT01059214?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.